ID

16754

Beschrijving

Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line Treatment of Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00079872

Link

https://clinicaltrials.gov/show/NCT00079872

Trefwoorden

  1. 04-08-16 04-08-16 -
Geüploaded op

4 augustus 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Colorectal Cancer NCT00079872

Eligibility Colorectal Cancer NCT00079872

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
the patient must have:
Beschrijving

ID.1

Datatype

boolean

histologic or cytologic diagnosis of adenocarcinoma of the colon or rectum.
Beschrijving

Adenocarcinoma of colon | Adenocarcinoma of rectum

Datatype

boolean

Alias
UMLS CUI [1]
C0338106
UMLS CUI [2]
C0149978
performance status of 0 to 2 on the ecog performance status scale.
Beschrijving

ECOG performance status

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
standard postoperative adjuvant radiation therapy for rectal cancer is allowed.
Beschrijving

adjuvant postoperative radiation therapy Rectal Carcinoma

Datatype

boolean

Alias
UMLS CUI [1,1]
C3162256
UMLS CUI [1,2]
C0007113
locally advanced or metastatic disease.
Beschrijving

Locally Advanced Malignant Neoplasm | Neoplasm Metastasis

Datatype

boolean

Alias
UMLS CUI [1]
C0677984
UMLS CUI [2]
C0027627
must be 18 years of age.
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
the patient must not have:
Beschrijving

ID.7

Datatype

boolean

received prior chemotherapy for advanced disease. prior adjuvant therapy, including 5-fu, is allowed if it has been more than 12 months since the last treatment.
Beschrijving

Prior Chemotherapy advanced disease | Prior Adjuvant Therapy | Fluorouracil

Datatype

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0679246
UMLS CUI [2]
C1514456
UMLS CUI [3]
C0016360
received prior treatment with irinotecan in the adjuvant setting.
Beschrijving

irinotecan | Prior Adjuvant Therapy

Datatype

boolean

Alias
UMLS CUI [1]
C0123931
UMLS CUI [2]
C1514456
are unable to take vitamin b12 or folic acid.
Beschrijving

Able to take medication Vitamin B 12 | Able to take medication Folic Acid

Datatype

boolean

Alias
UMLS CUI [1,1]
C4075001
UMLS CUI [1,2]
C0042845
UMLS CUI [2,1]
C4075001
UMLS CUI [2,2]
C0016410
are unable to interrupt aspirin, other nonsteroidal anti-inflammatory drugs, or cox-2 inhibitors for a 5-day period.
Beschrijving

Aspirin Interrupt Unable | Non-Steroidal Anti-Inflammatory Agents Interrupt Unable | Cyclooxygenase 2 Inhibitors Interrupt Unable

Datatype

boolean

Alias
UMLS CUI [1,1]
C0004057
UMLS CUI [1,2]
C0443239
UMLS CUI [1,3]
C1299582
UMLS CUI [2,1]
C0003211
UMLS CUI [2,2]
C0443239
UMLS CUI [2,3]
C1299582
UMLS CUI [3,1]
C1257954
UMLS CUI [3,2]
C0443239
UMLS CUI [3,3]
C1299582
have a second primary malignancy except carcinoma in situ of the cervix or nonmelanomatous skin cancer, unless that prior malignancy was diagnosed and definitively treated at least 5 years previously with no subsequent evidence of recurrence.
Beschrijving

Second Primary Cancer | Carcinoma in situ of uterine cervix | Skin carcinoma | Malignant Neoplasm Previous Treated Definitive | Recurrence Evidence

Datatype

boolean

Alias
UMLS CUI [1]
C0751623
UMLS CUI [2]
C0851140
UMLS CUI [3]
C0699893
UMLS CUI [4,1]
C0006826
UMLS CUI [4,2]
C0205156
UMLS CUI [4,3]
C1522326
UMLS CUI [4,4]
C0443196
UMLS CUI [5,1]
C0034897
UMLS CUI [5,2]
C3887511

Similar models

Eligibility Colorectal Cancer NCT00079872

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
the patient must have:
boolean
Adenocarcinoma of colon | Adenocarcinoma of rectum
Item
histologic or cytologic diagnosis of adenocarcinoma of the colon or rectum.
boolean
C0338106 (UMLS CUI [1])
C0149978 (UMLS CUI [2])
ECOG performance status
Item
performance status of 0 to 2 on the ecog performance status scale.
boolean
C1520224 (UMLS CUI [1])
adjuvant postoperative radiation therapy Rectal Carcinoma
Item
standard postoperative adjuvant radiation therapy for rectal cancer is allowed.
boolean
C3162256 (UMLS CUI [1,1])
C0007113 (UMLS CUI [1,2])
Locally Advanced Malignant Neoplasm | Neoplasm Metastasis
Item
locally advanced or metastatic disease.
boolean
C0677984 (UMLS CUI [1])
C0027627 (UMLS CUI [2])
Age
Item
must be 18 years of age.
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.7
Item
the patient must not have:
boolean
Prior Chemotherapy advanced disease | Prior Adjuvant Therapy | Fluorouracil
Item
received prior chemotherapy for advanced disease. prior adjuvant therapy, including 5-fu, is allowed if it has been more than 12 months since the last treatment.
boolean
C1514457 (UMLS CUI [1,1])
C0679246 (UMLS CUI [1,2])
C1514456 (UMLS CUI [2])
C0016360 (UMLS CUI [3])
irinotecan | Prior Adjuvant Therapy
Item
received prior treatment with irinotecan in the adjuvant setting.
boolean
C0123931 (UMLS CUI [1])
C1514456 (UMLS CUI [2])
Able to take medication Vitamin B 12 | Able to take medication Folic Acid
Item
are unable to take vitamin b12 or folic acid.
boolean
C4075001 (UMLS CUI [1,1])
C0042845 (UMLS CUI [1,2])
C4075001 (UMLS CUI [2,1])
C0016410 (UMLS CUI [2,2])
Aspirin Interrupt Unable | Non-Steroidal Anti-Inflammatory Agents Interrupt Unable | Cyclooxygenase 2 Inhibitors Interrupt Unable
Item
are unable to interrupt aspirin, other nonsteroidal anti-inflammatory drugs, or cox-2 inhibitors for a 5-day period.
boolean
C0004057 (UMLS CUI [1,1])
C0443239 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0003211 (UMLS CUI [2,1])
C0443239 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
C1257954 (UMLS CUI [3,1])
C0443239 (UMLS CUI [3,2])
C1299582 (UMLS CUI [3,3])
Second Primary Cancer | Carcinoma in situ of uterine cervix | Skin carcinoma | Malignant Neoplasm Previous Treated Definitive | Recurrence Evidence
Item
have a second primary malignancy except carcinoma in situ of the cervix or nonmelanomatous skin cancer, unless that prior malignancy was diagnosed and definitively treated at least 5 years previously with no subsequent evidence of recurrence.
boolean
C0751623 (UMLS CUI [1])
C0851140 (UMLS CUI [2])
C0699893 (UMLS CUI [3])
C0006826 (UMLS CUI [4,1])
C0205156 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
C0443196 (UMLS CUI [4,4])
C0034897 (UMLS CUI [5,1])
C3887511 (UMLS CUI [5,2])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial